The observations patients make between appointments are easy to lose and hard to replace. Folia turns them into useful records - and pays eligible contributors when they share them for research.
Embleema is a New York- and France-based healthcare technology company that builds a unified real-world data and evidence platform for clinical research. It aggregates clinical, genomic, and patient-reported data from electronic medical records, wearables, biospecimens, and patient apps into regulatory-grade datasets, and uses no-code protocol tools plus dynamic consent to help pharmaceutical sponsors, research sites, and patient groups run non-interventional and Phase IV studies faster and at lower cost. Founded in 2017 by Robert Chu, the company started with a patient-driven health blockchain and its analytics stack has been used by the FDA for genomic regulatory review.
Matthew Gitelis is the founder and CEO of PatientIQ, a Chicago-based healthcare analytics platform that automates the collection of patient-reported outcomes and turns them into actionable insight for providers. A former BMO Capital Markets investment banking analyst who then enrolled at Rush Medical College, he founded PatientIQ in 2016 after watching clinicians extract outcomes data by hand. He left medical school in 2019 to run the company full-time. Under his leadership PatientIQ has grown into a national network reaching hundreds of healthcare organizations, thousands of care sites, and millions of patients, and raised roughly $26M in venture funding through a 2022 Series B.
PatientIQ is a Chicago-based healthcare technology company that builds a cloud platform for systematically collecting, measuring, and analyzing patient-reported outcomes (PROs). Founded in 2016 by Matthew Gitelis, the company connects hospitals, health systems, private practices, and medical device makers on a single EHR-integrated system that turns outcomes data into actionable clinical and operational intelligence. PatientIQ has grown to serve more than 200 healthcare organizations and has collected outcomes data from over 1.4 million patients.
Avant-garde Health is a Boston-based healthcare data analytics company whose CareMeasurement platform helps hospitals, ambulatory surgery centers and physicians measure the true cost, quality and processes of surgical care - then turn those insights into measurable savings and better patient outcomes. Founded in 2014 out of value-based care research at Harvard Business School, the company applies Time-Driven Activity-Based Costing (TDABC) across EMR, financial, claims and patient-reported outcomes data to reveal what was previously invisible inside the operating room and the care pathway around it.